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Abstract
Background: Main contributors to adverse outcomes in severely burned pediatric patients are profound and complex
metabolic changes in response to the initial injury. It is currently unknown how long these conditions persist beyond the
acute phase post-injury. The aim of the present study was to examine the persistence of abnormalities of various clinical
parameters commonly utilized to assess the degree hypermetabolic and inflammatory alterations in severely burned
children for up to three years post-burn to identify patient specific therapeutic needs and interventions.
Methodology/Principal Findings: Patients: Nine-hundred seventy-seven severely burned pediatric patients with burns over
30% of the total body surface admitted to our institution between 1998 and 2008 were enrolled in this study and compared
to a cohort non-burned, non-injured children. Demographics and clinical outcomes, hypermetabolism, body composition,
organ function, inflammatory and acute phase responses were determined at admission and subsequent regular intervals
for up to 36 months post-burn. Statistical analysis was performed using One-way ANOVA, Student’s t-test with Bonferroni
correction where appropriate with significance accepted at p,0.05. Resting energy expenditure, body composition,
metabolic markers, cardiac and organ function clearly demonstrated that burn caused profound alterations for up to three
years post-burn demonstrating marked and prolonged hypermetabolism, p,0.05. Along with increased hypermetabolism,
significant elevation of cortisol, catecholamines, cytokines, and acute phase proteins indicate that burn patients are in a
hyperinflammatory state for up to three years post-burn p,0.05.
Conclusions: Severe burn injury leads to a much more profound and prolonged hypermetabolic and hyperinflammatory
response than previously shown. Given the tremendous adverse events associated with the hypermetabolic and
hyperinflamamtory responses, we now identified treatment needs for severely burned patients for a much more prolonged
time.
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Introduction
Despite significant advances in therapeutic strategies, e.g.,
improving resuscitation, enhancing wound coverage, appropriate
infection control, and improving treatment of inhalation injury,
severe burns remain a devastating injury affecting nearly every
organ system and leading to significant morbidity and mortality
[1]. Main contributors to adverse outcomes of severely burned
patients are profound and complex metabolic changes in response
to the initial burn [1,2]. Burns covering more than 30% total body
surface area (TBSA) are associated with stress, inflammatory, and
hypermetabolic responses that lead to hyperdynamic circulation,
increased body temperature, glycolysis, proteolysis, lipolysis and
futile substrate cycling [3–5]. These responses are present in all
trauma, surgical, or critically ill patients, but the severity and
magnitude is unique for burn patients [1]. Marked and sustained
increases in catecholamine, glucocorticoid, glucagon, and dopa-
mine secretion are thought to initiate the cascade of events leading
to the acute hypermetabolic response with its ensuing catabolic
state [3,6–13].
Several studies have indicated that these metabolic phenomena
post-burn occur in a timely manner, suggesting two distinct
patterns of metabolic regulation following injury [14]. The first
phase occurs within the first 48 hours of injury and has classically
been called the ‘‘ebb phase’’ [14,15], characterized by decreases in
cardiac output (CO), oxygen consumption, and metabolic rate as
well as impaired glucose tolerance associated with its hyperglyce-
mic state. These metabolic variables gradually increase within the
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first five days post-injury to a plateau phase (called the ‘‘flow’’
phase) associated with hyperdynamic circulation and the above
mentioned hypermetabolic state. In the past, general understand-
ing has been that these metabolic alterations resolve with complete
wound closure or shortly thereafter [16]. Recent studies, however,
are indicative that the hypermetabolic response to burn injury
persists beyond wound closure, e.g., we have recently shown that
alterations in insulin sensitivity persisted for three years after the
initial burn injury [17]. In light of these findings, we hypothesized
that a burn injury induces vast hypermetabolic and inflammatory
alterations associated with physiologic changes that persist not only
for 6 to 12 months post-burn but for three years. To test our
hypothesis, we conducted a large prospective study in severely
burned pediatric patients and determined hypermetabolic and
inflammatory responses over a period of three years post-burn.
Results
Demographics
Nine-hundred seventy-seven severely burned children were
included in the present study. Characteristics of burn patients are
depicted in Table 1. Patients were, on average, 7.5 years of age,
36% were females and 64% were males. Patients suffered from a
severe thermal injury involving 50% TBSA burn and a third-
degree burn of 37% TBSA. During acute hospitalization, length of
hospital/ICU stay was 26 days which results in 0.5 days per
percent TBSA burn. Patients were taken back to the OR every 7th
day and required on average 4 operations. During acute
hospitalization, 32% of the patients suffered from inhalation
injury, minor infections occurred in 43% of the patients, sepsis
occurred in 10%, multi-organ failure in 16%, and 8% of our
patients died (Table 1).
Hypermetabolism
Indirect calorimetry. Predicted REE increased significantly
post-burn and then gradually decreased over time, but remained
significantly elevated for two years following burn injury indicating
marked hypermetabolism, p,0.05 (Fig. 1A).
Body composition, weights and heights. Bone mineral
content (Fig. 1B), LBM (Fig. 1C), fat (Fig. 1D, E) and BMD
(Fig. 1F, G) were measured at admission and subsequent time
points. DEXA analysis revealed significantly decreased values
throughout the whole time period studied for BMC, LBM, and fat,
p,0.05 (Fig. 1B–E). BMD was not significantly different from
normal (Fig. 1F, G).
On admission, the patient population fell within essentially the
normal distribution pattern for both height and weight. Thirty-six
percent of the patient population fell below the 50th percentile (the
mean) for height at admission, while the percentage of burned
children that fell below the 50th percentile for height was
significantly greater for up to two years post-burn, indicating a
profound growth delay in this patient population. Forty-two
percent of the patients included this study were below the mean for
weight at admission, while the percentage of burned children that
fell below the 50th percentile for weight was significantly greater
for up to three years post burn, p,0.05. Data demonstrate that it
takes approximately 1–2 years for pediatric burn patients to grow
again and improve their height and weight percentile.
Organ changes. Analysis of CO, CI and HR revealed
marked alterations in response to burn. CO increased immediately
post-burn and remained significantly elevated over 12 months
before gradually decreasing to values of non-burned controls
(Fig. 1H). CI was also significantly elevated during the first 12
months post-burn before returning to values of non-burned
patients for the remaining of the study (Fig. 1I). While HRs of
severely burned pediatric patients vastly increased immediately
after burn to values of 17366% with that of non-burned children,
and remained significantly increased over 3 years post-burn, SV of
these children was not significantly different from that of normal
controls (Fig. 1J, K).
Analysis of liver size determined by ultrasounds demonstrated
markedly increased liver size in response to the initial burn trauma
for up to three years, p,0.05 (Fig. 1L). Throughout the time
period studied, liver size of severely burned children was increased
by an average of 75% compared to healthy non-burned children
of similar age. Interestingly, we did not detect a decrease in liver
size over the three-year study period.
Inflammatory and acute phase response
Urinary catecholamine and cortisolmeasurements. Urinary
norepinephrine, epinephrine, and cortisol increased markedly
immediately after burn trauma. Urinary norepinephrine increased
10-fold during the early phase post-burn and remained significantly
elevated up to 540 days post-burn when compared with non-burned
control patients, p,0.05 (Fig. 2A). Urinary epinephrine levels
significantly increased 4- to 5-fold post-burn and remained elevated
for 60 days post-burn, p,0.05 (Fig. 2B). Total urine cortisol levels
initially increased 8- to 10-fold and levels remained significantly
Table 1. Patient demographics.
N 977
Gender
Male n (%) 627 (64)
Female n (%) 350 (36)
Ethnicity
AA 69
C 141
H 738
Other 29
Age admit (years) 7.565.3
Inhalation Injury n (%) 308 (32)
Type of burn
Flame (n) 721 (74)
Scald (n) 200 (21)
Other (n) 56 (25)
TBSA burn (%) 50620
TBSA second (%) 21617
TBSA third (%) 37626
Burn to admit (days) 13634
Operations acutely (n) 3.763.2
Time between OR’s (days) 665
LOS ICU (days) 26.2625.5
LOS/TBSA (days) 0.560.4
Died n (%) 75 (8)
Max DENVER2 3.261.8
MOF n (%) 155 (16)
Sepsis n (%) 93 (10)
Patients with minor infections n (%) 420 (43)
TBSA = total body surface area. Data presented as means 6 SD or percentages.
doi:10.1371/journal.pone.0021245.t001
Postburn Responses
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Figure 1. Persistently increased percent predicted REE indicate prolonged hypermetabolism (A). REE % predicted increases upon burn
injury and decreased over time but remains significantly elevated up to two years post-injury. Bars represent means; error bars correspond to S.E.M.
Asterisks denote statistical difference between burned children vs. normal range, p,0.05. Body composition, weights and heights: Bone mineral
content (B), LBM (C), fat (D, E) and BMD (F, G) were measured at admission and subsequent time points. DEXA analysis revealed significantly
decreased values throughout the whole time period studied for BMC, LBM, and fat, p,0.05. Cardiac function and liver size post-burn: Percent
predicted cardiac output (H) and cardiac index (I) were significantly increased for up to 12 months post-burn. Heart rate (J) was twice that of non-
burned children for up to three years post-burn, while predicted stroke volume (K) was normal. Liver size increased by nearly two-fold upon burn
injury of predicted liver size and remained elevated for the remaining of the study (L). Bars represent means; error bars correspond to S.E.M. Asterisks
denote statistical difference between burned children vs. non-burned children, p,0.05.
doi:10.1371/journal.pone.0021245.g001
Postburn Responses
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increased 3 years post-burn, p,0.05 (Fig. 2C). Serum cortisol
measurements displayed similar characteristics and levels were
significantly increased up to 3 years post-burn, p,0.05 (Fig. 2D).
Serum cytokines. We found that almost all cytokines
measured within this study were significantly altered in response
to burn injury (Fig. 3A–Q). Dramatic changes were observed for
serum IL-6, IL-8, G-CSF and MCP-1 (Fig. 3C, D, M, N). These
cytokines demonstrated an up to 2,000-fold increase immediately
upon burn trauma and remained significantly elevated throughout
the time period studied when compared with the concentrations
detected in non-burned controls, p,0.05. GM-CSF, INF-c, TNF-
a, IL-1b, IL-2, IL-5, IL-7, IL-10, and IL-17 significantly increased
by 2- to 20-fold in response to burn injury and revealed relatively
constant, but significantly increased levels for most of the three-
year period post-burn compared to non-burned patients (p,0.05).
IL-12p70 and MIP-1b were not significantly altered in response to
burn trauma when compared to controls.
Serum proteins. Serum acute phase proteins were significantly
altered upon burn injury (Fig. 4A–L). Serum complement C3
concentrations initially demonstrated significantly diminished levels
compared to those of non-burned controls, before peaking at 29 to 90
days post-burn with significantly elevated levels and then rapidly
decreased to basal levels for the remaining of the study period,
p,0.05 (Fig. 4A). Serum a2-macroglobulin concentrations displayed
significantly decreased values for up to 60 days post-burn before
gradually increasing to levels of non-burned controls, p,0.05
(Fig. 4B). Serum haptoglobin, a1-acidglycoprotein, and CRP
demonstrated a 2- to 12-fold increase immediately upon burn
injury and remained significantly elevated for up to 90 and 270 days
post-burn, respectively, compared to non-burned controls, p,0.05
(Fig. 4C–E). Serum constitutive hepatic proteins retinol-binding
protein, pre-albumin and transferrin markedly decreased by 2-fold
immediately post-burn and remained significantly decreased for up to
90 days post-burn, p,0.05 (Fig. 4F–H). Serum apolipoprotein A1
Figure 2. Urinary norepinephrine (A) and epinephrine (B) are significantly increased for two and 18 months post-burn, respectively.
Twenty-four hour total urine cortisol (C) and serum cortisol (D) levels increase upon burn injury and remain significantly elevated for up to 36 months.
Bars represent means; error bars correspond to S.E.M. Asterisks denote statistical difference between burned children vs. non-burned children,
p,0.05.
doi:10.1371/journal.pone.0021245.g002
Postburn Responses
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Figure 3. Severe burn leads to markedly increased inflammatory response. Fourteen cytokines measured within this study were
significantly altered in response to burn injury. Particularly serum IL-6, IL-8, G-CSF and MCP-1 revealed dramatic increases. IL-12p70 and MIP-1b were
not significantly altered in response to burn trauma when compared to controls. Histograms depict serum concentrations of the respective cytokine
at steady state levels. Bars represent means; error bars correspond to S.E.M. Asterisks denote statistical difference between burned children vs. non-
burned children, p,0.05.
doi:10.1371/journal.pone.0021245.g003
Postburn Responses
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significantly decreased post-burn and remained significantly
diminished for a period of 90 days, p,0.05 (Fig. 4I).
Apolipoprotein B demonstrated a diminutive initial decrease then
steadily increased to significantly elevated levels between 41 and 90
days before gradually decreasing to basal levels of non-burned
patients, p,0.05 (Fig. 4J). Serum triglycerides gradually increased
upon burn injury and demonstrated significantly elevated levels
between 17 to 180 days post trauma (Fig. 4K).
Serum glucose significantly increased immediately upon burn
injury to levels of 15662 mg/dl and remained significantly
elevated for a period of 180 days before gradually decreasing to
levels within the normal physiologic range, p,0.05 (Fig. 4L).
Serum insulin levels also rapidly increased to significant levels in
response to burn, before subsequently decreasing but remaining
significantly elevated for the whole time period studied when
compared with the serum concentrations detected in non-burned
controls, p,0.05 (Fig. 4M).
Serum concentrations of Alanin-Aminotransferase (ALT) and
aspartat-aminotransferase (AST) significantly increased immedi-
ately upon burn trauma and remained significantly elevated for
Figure 4. Serum proteins. Acute phase proteins and constitutive proteins are significantly altered for up to 18 months post-burn. Serum
complement C3 (A), a2-macroglobulin (B), haptoglobin (C), a1-acidglycoprotein (D), and CRP (E) were significantly increased for up to nine months
post-burn. Serum constitutive hepatic proteins retinol binding protein (F), pre-albumin (G), transferrin (H) markedly decreased immediately post-burn
and remained diminished for up to six months post-burn. Serum apolipoprotein A1 (I) and apolipoprotein B (J) were markedly decreased for 18 and
one month, respectively. Serum triglycerides (K) demonstrated significantly increased levels for nine months post-burn. Burn trauma leads to
hyperglycemia and elevated fasting serum insulin concentrations, indicating insulin resistance. Histograms depict fasting serum concentrations of (L)
glucose and (M) insulin. Bars represent means; error bars correspond to S.E.M. Asterisks denote statistical difference between burned children vs. non-
burned children, p,0.05.
doi:10.1371/journal.pone.0021245.g004
Postburn Responses
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the remaining of the study period, p,0.05 (Fig. 5A, B). Serum
Albumin (ALB) concentrations demonstrated significantly de-
creased levels for the entire three-year period compared to non-
burned controls, p,0.05 (Fig. 5C). Both, alkaline phosphatase
(ALP) and gamma glutamyl transpeptidase (GGT) were signifi-
cantly altered in response to burn. While ALP displayed
significantly elevated levels starting 8 days post-burn injury, which
remained significantly elevated for the remaining of the study,
serum concentrations of GGT raised to significant values
beginning eight days post-burn before rapidly decreasing to
normal concentrations beginning 90 days post-trauma, p,0.05
(Fig. 5D, E). Serum calcium concentrations, however, displayed
significantly decreased levels for the entire three-year period,
p,0.05 (Fig. 5F).
Serum hormones. All serum hormones measured within this
study demonstrated significant alterations in response to burn
trauma. Serum levels of both, insulin growth factor (IGF)-I and
insulin-like growth factor binding protein-3 (IGF BP-3), decreased
significantly immediately post-burn and remained diminished for
most of the remaining study period, compared to levels of non-
burned controls, p,0.05 (Fig. 5G, H). Human growth hormone
(hGH) gradually declined in response to burn injury over the time
period studied and demonstrated significantly decreased values for
several of the time points within the three-year period when
Figure 5. Hepatic enzymes and proteins. Histograms depict serum concentrations of Alanin-Aminotransferase (ALT) (A), aspartat-
aminotransferase (AST) (B), albumin (ALB) (C), alkaline phosphatase (ALP) (D), glutamyl transpeptidase (GGT) (E), and serum calcium concentrations
(F). Serum IGF-I (G), IGFBP-3 (H), GH (I), iPTH (J), osteocalcin (K), EST (L) were significantly decreased in response to thermal injury and remained
diminished for up to three years post-burn. Analysis of serum testosterone (M) and progesterone (N) revealed only moderate increases throughout
the first two months post-burn. Bars represent means; error bars correspond to S.E.M. Asterisks denote statistical difference between burned children
vs. non-burned children, p,0.05.
doi:10.1371/journal.pone.0021245.g005
Postburn Responses
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compared to controls, p,0.05 (Fig. 5I). Serum parathormone
(iPTH) decreased by 8-fold immediately post-burn and remained
significantly decreased for three years post-burn, p,0.05 (Fig. 5J).
Serum levels of osteocalcin also displayed significantly decreased
values for a time period of 270 days before rapidly increasing to
levels of non-burned controls, p,0.05 (Fig. 5K). Serum
concentrations of estrogen (EST), testosterone (TEST) and
progesterone (PROG) displayed diverse patterns post-burn
injury. While serum estrogen decreased immediately post-burn
and remained significantly decreased for the entire time period
studied, p,0.05 (Fig. 5L), serum testosterone gradually increased
upon burn trauma with significant levels at 8 to 10 days post-burn,
respectively, before gradually decreasing to diminished levels
beginning 60 days post-burn, p,0.05 (Fig. 5M). Serum
progesterone concentrations displayed significantly elevated
levels for the first two years post-burn before gradually
decreasing to values of non-burned controls, p,0.05 (Fig. 5N).
Discussion
The importance of this study is that it clearly demonstrated that
burn induced metabolic and inflammatory changes persisted for 3
years after the injury. The relevance of post-burn hypermetabo-
lism and inflammation is that they induce insulin resistance for 3
years [17], 50- to 100-fold increase in fracture risk [1], 200%
increase in liver-size [18,19], growth and development retardation
for 2–3 years [3], increased cardiac work and develop cardiac
dysfunction [20], impaired strength [3,20], muscle function,
hormonal abnormalities [17,18], increased risk for infections and
sepsis [3,20]. All the aforementioned can lead to morbidity and
mortality of the patient. We now showed that this risk to die is not
over when the patient is 95% healed; it persists for up to 3 years
post-burn.
Even though the metabolic alterations after severe burn injury
are similar to any major trauma, severe burns are characterized by
a hypermetabolic response that is more severe and sustained than
any other form of trauma [16]. Several studies have extensively
delineated the complexity of the acute post-burn pathophysiologic
response [14,15,18]; however, it is currently unknown how long
these metabolic phenomena persist beyond the first 12 months
after the initial event [6,13,21,22]. Marked and sustained increases
in catecholamine, glucocorticoid, and glucagon secretion are
thought to initiate the cascade of events leading to the acute
hypermetabolic response with its ensuing catabolic state [3,6–13].
Contrary to past understanding that these metabolic mediators
resolve soon after complete wound closure [16], we could
demonstrate catecholamines and stress hormones such as cortisol
were elevated for up to 36 months post-burn accompanied by
significant increases in REE indicative of vast hypermetabolism.
Resting metabolic rates in burn patients have been shown to
increase in a curvilinear fashion, ranging from near normal for
burns less than 10% TBSA to twice that of normal in burns more
than 40% TBSA. In patients with burn injuries greater than 40%
TBSA, resting metabolic rate at thermally neutral temperature
(33uC) reaches up to 180% of the basal rate during acute
admission, 150% at full healing of the burn wound, 140% at six
months after the injury, 120% at nine months after injury, and
110% after 12 months [3]. In this study, we could demonstrate
that even three years after the initial trauma REE is still above
normal, indicating a persistent hypermetabolic response. The
exact cause of this complex response, however, is still poorly
understood. IL-1 and -6, platelet-activating factor, TNF, endo-
toxin, neutrophil-adherence complexes, reactive oxygen species,
nitric oxide and coagulation as well as complement cascades, all
have been implicated in regulating this response to burn injury
[23]. Here, we found marked alterations for 14 cytokines in
response to burn injury. Particularly, serum IL-6, IL-8, G-CSF
and MCP-1 displayed dramatic changes. These cytokines
demonstrated an up to 2000-fold increase immediately post-burn
and remained significantly elevated throughout the time period
studied. Cytokines are the primary mediators of this inflammatory
reaction to injury [24]. They constitute a group of proteins with
autocrine and endocrine activities that provide communication
among different types of cells, including those that mediate
immune functions, angiogenesis, cell proliferation and apoptosis
[24]. Inflammatory cytokines such as TNF, IL-6 and MCP-1 have
been also shown to inhibit insulin action through modification of
signaling properties of insulin receptor substrates, contributing to
liver and skeletal muscle insulin resistance [25–27].
Persistently increased glucose and insulin levels as shown in this
study are of serious clinical concern since hyperglycemia has been
frequently linked to impaired wound healing [28], increased skin
graft loss [29], increased muscle protein catabolism [30], increased
incidence of infections [31,32] and mortality [2,31–35]. Main-
taining blood glucose at levels below 110 mg/dl using intensive
insulin therapy has been shown to reduce mortality and morbidity
in critically ill patients [36]; however, associated hypoglycemic
events have led to the investigation of alternative strategies,
including the use of metformin [37] and the PPAR-c agonist
fenofibrate [38]. Other underlying factors for the observed
elevated glucose and insulin levels may include the above
mentioned prolonged increases in endogenous stress hormones,
which have been causally associated with injury-induced insulin
resistance [8–13]. Also, decreases in muscle mass, both during the
acute and recovery phases following injury, may significantly
contribute to this persistent insulin resistance, since skeletal muscle
has been shown to be responsible for 70–80% of whole-body
insulin-stimulated glucose uptake [39]. In contrast to starvation, in
which lipolysis and ketosis provide energy and protect muscle
reserves, burn injury considerably reduces the ability of the body
to utilize fat as an energy source. Skeletal muscle is thus the major
source of fuel in the burned patient, which leads to marked wasting
of LBM within days after injury [1,40], as shown in our burned
patients. Increased protein turnover, degradation, and negative
nitrogen balance are common characteristics of severe burn
trauma [41]. As a consequence, structure and function of essential
organs such as skeletal muscle, skin, immune system, and cellular
membrane transport functions may be compromised [42,43]. In
1998, Chang and colleagues [44] defined that a 10% loss of LBM
may lead to impaired immune function, a 20% loss of LBM to
impaired wound healing with an associated 30% mortality, a 30%
loss of LBM to pneumonia and pressure sores with an associated
50% mortality, and a 40% loss of LBM may ultimately result in
death in 100% of cases.
Other significant observations in this large prospective trial
include substantially affected expression of acute phase proteins.
Particularly haptoglobin, a1-acidglycoprotein, and CRP demon-
strated significant increases for up to nine months post-burn.
Serum constitutive hepatic proteins, in contrast, such as retinol-
binding protein, pre-albumin and transferrin, were found to be
significantly decreased for up to six months post-injury. This
decrease could be due to decreased production, increased
consumption or increased loss due to capillary leakage. These
proteins represent commonly utilized markers for general
homeostasis indicating the severity and intensity of the prolonged
post-burn dysbalance [18]. Determinations of serum triglycerides
revealed significant increases for nine months post-trauma, a
finding which may help explain the commonly observed fatty
Postburn Responses
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infiltration of liver and other organs of burn victims. A recently
demonstrated association between hepatomegaly with fatty
infiltration and increased incidence of sepsis and mortality
supports the importance of this observation [45]. After thermal
injury, a variable degree of liver injury is present, and it is usually
related to the severity of the thermal injury. Fatty changes, a very
common finding, are per se reversible and their significance
depends on the cause and severity of accumulation [45–50]. In this
study, analysis of liver ultrasounds demonstrated markedly
increased liver size in response to the initial burn trauma for up
to three years. Other hepatic parameters utilized to determine
liver function, including ALT and AST, were significantly altered
for the entire study period, also indicating that liver damage is
present for a prolonged period post-trauma. As described
previously by our group, serum apolipoprotein A1 significantly
decreased upon burn trauma and remained significantly dimin-
ished for three years, apolipoprotein B, in contrast, only
demonstrated diminutive initial decreases before returning to
normal values [18]. The exact role of these two proteins in this
context, however, remains to be determined.
As recently demonstrated by Jeschke et al. [18] in the acute
phase post-burn, several hormonal axes are affected by burn
trauma. Overall, critical illness is characterized by marked
alterations in the hypothalamic-anterior-pituitary-peripheral-
hormone axes, the severity of which is associated with a high
risk of morbidity and mortality [51]. Within this study, we also
found prolonged alterations in GH-IGF-I-IGFBP-3-axis, PTH-
Osteocalcin axis, and sex hormones (testosterone, b-estradiol,
progesterone). Particularly, serum levels of IGF-I and IGF BP-3
demonstrated a substantial decrease for up to three years post-
burn while measured levels of hGH were rather moderately
decreased for the whole time period studied. Beneficial effects of
recombinant human growth hormone (rhGH) in trauma patients
have been demonstrated in various settings. Besides enhancing
immune function [52,53], wound healing [54], and decreasing
the overall hypermetabolic response after major surgery, trauma,
sepsis or a thermal injury [55–57], rhGH stimulates protein
synthesis and attenuates the nitrogen loss after injury and
improves clinical outcomes [58]. Also, rhGH modulates the
hepatic acute phase response by increasing constitutive hepatic
proteins, decreasing acute phase proteins, modulating cytokine
expression, and increasing IGF-I concentrations [59,60]. How-
ever, ever since rhGH administration in trauma patients has been
shown to increase mortality in a prospective, randomized,
double-blind study by Takala and colleagues [61], the use of
rhGH has been restricted. Administration of IGF-I may thus
represent a promising therapeutic alternative, since recent
studies could demonstrate that IGF-I, in combination with its
principle binding protein, improved muscle protein synthesis,
hepatic acute phase and inflammatory response, and the
immune system [62–64].
Determination of serum osteocalcin and parathyroid hormone
levels also demonstrated significant decreases for nine and up to 36
months, respectively, associated with profound decreases in BMC
and BMD. As shown by Klein and others [10,65–70] using labeled
tetracycline in order to determine bone turnover rates, severely
burned patients are lacking overall bone formation and synthesis.
Besides administration of pamidronate, which was recently shown
to improve bone metabolism during the acute phase and long-
term phase post-burn [69], sex hormone substitution may
represent a potential therapeutic approach. Particularly, since
estrogen levels were diminished for the whole time period studied
and estrogen substitution has been shown to improve bone
mineralization and metabolism [71].
Analysis of various cardiac parameters showed marked
alterations in response to burn. Percent of normal CO as well as
CI were significantly elevated during the first 180 days post-burn,
accompanied by a massive tachycardia with 120–180% predicted
HR for the whole time period studied. Elevated levels of plasma
catecholamines instigate the cardiac stress post-burn. Plasma
catecholamine levels are elevated up to nine months post-burn,
but the derangements in cardiac physiology last up to three-years
after the initial trauma. Elevated catecholamines increase
myocardial oxygen delivery, myocardial oxygen consumption
and cause focal degeneration of the myocardium and hypertrophy.
In excess, they cause cardiac deficiency, local myocardial hypoxia,
and cardiac death [72]. Thus, prolonged exposure to catechol-
amine levels 10-fold higher than normal is cause for clinical
concern. However, the long-term ramifications of the cardiac
stress seen post-burn is still unknown. Initially, it was thought that
these derangements would subside shortly after the acute
hospitalization or the initial resuscitation. More recent research
has shown that these responses may last 9–12 months after the
initial insult [16,73,74]. Here, we demonstrated a significant
increase in cardiac work up to three years after the initial injury.
This may be a profound detriment to our pediatric burn patients
by increasing morbidity and leading to long-term cardiac
exhaustion, or cardiovascular complications in the future. These
findings support the use of an anti-catabolic agent to attenuate the
effects of increased catecholamines, beta-adrenergic regulation,
and the need for cardiovascular protection.
Therapeutic advancements in the acute phase post-burn, such
as early excision and closure of the burn wound, more appropriate
infection control and anti-catabolic therapeutic intervention,
including beta-adrenergic blockade with propranolol, growth
hormone, insulin-like growth factor, oxandrolone, testosterone,
and insulin have substantially contributed to significant improve-
ment of morbidity and mortality rates in burn patients during
acute hospitalization. However, based on this study, we suggest
that a severe burn is not an acute illness but rather a chronic
health problem. We thus believe that burn patients should be
carefully monitored for at least 3–4 years in order to reverse these
complex metabolic alterations post-burn.
Materials and Methods
Patients
All thermally injured pediatric patients with burns covering
more than 30% of their TBSA were admitted to our institution
between 1998 and 2008, required at least one surgical interven-
tion, and consented to the University of Texas Medical Branch
Institutional Review Board-approved experimental protocol were
included in this study. Patient, parent or legal guardian provided
with written consent for participation in the study.
Admission Data
On admission, the extent and degree of burn was assessed and
recorded on a standard Lund and Browder chart by the attending
burns surgeon present. Information also recorded at the time of
admission included burn related (date and mechanism) as well as
demographic data (age and gender). All patients were treated in
our pediatric burns intensive care unit according to standardized
protocols.
Patients were resuscitated if needed according to the Galveston
formula with 5000 cc/m2 TBSA burned +2000 cc/m2 TBSA
lactated Ringer’s solution given in increments over the first
24 hours. Within 24 hours of admission, all patients underwent
total burn wound excision and the wounds covered with available
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autograft skin and any remaining open areas were covered with
homograft. After the first operative procedure, it took 5–10 days
until the donor site was healed and patients were taken back to the
operation theater. This procedure was repeated until all open
wound areas were covered with autologous skin material.
All patients underwent the same nutritional treatment according
to a standardized protocol. The intake is calculated as 1500 kcal/m2
body surface +1500 kcal/m2 area burn or we assessed the need by
measuring the resting energy expenditure (REE), multiplied by 1.4
with weekly adjustments as previously published [6,22].
Patient demographics
Patient demographics (age, date of burn and admission, gender,
burn size and depth of burn) and concomitant injuries such as
inhalation injury, sepsis, morbidity, and mortality were recorded.
Minor infection was defined as a positive tissue culture with more
than 105 colony forming units per gram tissue. Sepsis was defined
as a positive blood culture or pathologic tissue culture identifying
the pathogen during hospitalization or at autopsy, in combination
with at least 3 of the following: leucocytosis or leucopenia
(.12,000 or ,4,000), hyperthermia or hypothermia (.38.5 or
,36.5uC), tachycardia (.150 BPM in children), refractory
hypotension (systolic BP ,90 mmHg), thrombocytopenia (plate-
lets ,50,000/mm3), hyperglycemia (serum glucose .240 mg/dl),
and enteral feeding intolerance (residuals .200 cc/hr or diarrhea
.1 L/day) as previously published [3,75]. Time between opera-
tions was determined as a measurement for wound healing/re-
epithelization. As demonstrated previously, we believe that time
between operations may be indicative when donor sites were
healed and thus allow determination of wound healing.
Time points
Results obtained during the three-year period were divided into
fifteen different time phases: 0 to7, 8 to 10, 11 to 16, 17 to 22, 23
to 28, 29 to 34, 35 to 40, 41 to 60, 61 to 90, 91 to 180, 181 to 270,
271 to 365, 366 to 540, 541 to 730 and 731 to 1,100 days post-
burn. Data presented include a number of 31 to 307 different
measurements at each time point. If any patient had more than
one measurement performed during the respective time period,
results were averaged to give a single mean result for each patient
at each time period. One-hundred seven non-burned children,
who consented for research studies and required blood and/or 24-
hour urine collections, were used as normal cohort.
Hypermetabolism
Indirect calorimetry. As part of our routine clinical
practice, all patients underwent REE measurements weekly
during acute hospitalization and during admissions for
reconstructive operations for up to three years post-burn. REE
was measured using a Sensor-Medics Vmax 29 metabolic cart
(Yorba Linda, CA, USA) as previously published [6]. REE was
calculated from the oxygen consumption and carbon dioxide
production by equations described before [6]. For statistical
comparison, measured energy expenditure was expressed as the
percentage of the basal metabolic rate predicted compared with
predicted norms based upon the Harris-Benedict equation and to
body mass index (BMI) [6].
Growth measurements and body composition. Heights
and weights were measured during acute hospitalization
subsequent stays for reconstructive purposes and were plotted on
standard growth charts [76] to obtain the individual height and
weight percentiles for age and gender. Percentages of the
population plotted within each percentile ranking were then
calculated. Total lean body mass (LBM), fat, bone mineral density
(BMD), and bone mineral content (BMC) were measured by dual
energy x-ray absorptiometry (DEXA). A hologic model QDR-
4500W DEXA (Hologic Inc, Waltham, MA) was used to
determine body composition as previously published [7,21,77,78].
Organ changes. M-Mode echocardiograms were completed
as follows: at the time of the study, none of the patients presented
with or previously suffered from other concomitant diseases
affecting cardiac function, such as diabetes mellitus, coronary
artery disease, long-standing hypertension, or hyperthyroidism.
Study variables included: resting CO, cardiac index (CI), stroke
volume (SV), resting heart rate (HR) and left ventricular ejection
fraction (LVEF). SV and CO were adjusted for body surface area
and expressed as indexes. All cardiac ultrasound measurements
were made with the Sonosite Titan echocardiogram with a
3.5 MHz transducer. Recordings were performed with the
subjects in a supine position and breathing freely. M-Mode
tracings were obtained at the level of the tips of the mitral leaflets
in the parasternal, long axis position and measurements were
performed according to the American Society of Echocardio-
graphy recommendations. Left ventricular volumes determined at
end diastole and end systole were used to calculate EF, SV, CO
and CI. Three measurements were performed and averaged for
data analysis [21,78]. Liver size was determined by ultrasound as
previously published [18].
Inflammatory and acute phase response
Urinary catecholamine and cortisolmeasurements. Twenty-
four-hour urine collections were taken regularly throughout acute
hospital stay and during admissions for reconstructive operations and
rehabilitation services. These samples were collected and chilled by the
bedside prior to transport to our clinical lab for processing using HPLC
techniques as previously published [17]. Extraction of the catecho-
lamines from acidified urine samples were performed using a Bio-Rad kit
(Bio-Rad, Hercules, CA), according to manufacturer’s instructions.
Serum cytokine, protein and hormonemeasurements. Blood
was collected from the burn patients at the time of admission, pre-
operatively, and every Monday and Thursday at 6:00 AM, as well as
during subsequent stays for surgical and rehabilitation services for serum
cytokine and hormone analysis per hospital protocol. Blood was drawn in
a serum-separator collection tube and centrifuged for 10 minutes at
1320 rpm; the serum was removed and stored at 270uC until assayed.
Serum hormones were determined using HPLC and ELISA
techniques. The Bio-Plex Human Cytokine 17-Plex panel was used
with the Bio-Plex Suspension Array System (Bio-Rad, Hercules, CA)
to profile expression of Interleukin (IL)-1b, IL-2, IL-4, IL-5, IL-6, IL-
7, IL-8, IL-10, IL- 12p70, IL-13, IL-17, granulocyte colony-
stimulating factor (GCSF), granulocyte-macrophage colony-stimu-
lating factor (GM-CSF), interferon-gamma (IFN-c), monocyte
chemoattractant protein-1 (MCP-1), macrophage inflammatory
protein-1-beta (MIP-1b), and tumor necrosis factor (TNF). The
assay was performed according to the manufacturer’s instructions.
Acute phase and constitutive protein levels were measured using BN
II Plasma Protein Analyzer (Dade Behring/Siemens Healthcare,
Deerfield, IL) by a nephelometric technique, according to manufac-
turer’s instructions.
Ethics and statistics
The study was reviewed and approved by the Institutional
Review Board of the University Texas Medical Branch, Galveston,
Texas. Prior to the study, each subject, parent or child’s legal
guardian signed a written informed consent form. Analysis of
variance (ANOVA) with post hoc Bonferroni correction, paired
and unpaired Student’s t-test, Chi-square analysis, and Mann-
Whitney tests were used where appropriate. Data are expressed as
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means6SD or SEM, where appropriate. Significance was
accepted at p,0.05.
Study oversight
This study was registered at www.clinicaltrials.gov: #NCT
00239668 and #NCT00673309. A steering committee consisting
of academic investigators designed the study and monitored its
conduct. Data were collected by the investigators and analyzed by
scientists. All the authors had access to the data, participated in the
data analysis and interpretation, and wrote the manuscript. All
authors vouch for the accuracy and completeness of the data and
the statistical analysis. All authors participated in the writing of the
manuscript and approved the final manuscript before submitting it
for publication.
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